No Data
No Data
Express News | Guosen Securities Says Regulator Orders Co to Rectify Irregularities, Suspend Filing of New Private Asset Management Products for Three Months Over Rule Violations
Guosen Securities: First Time Rating PICC P&C with "Outperform" Rating, Target Price HK$11.45-$12.10.
Guosen released a research report, giving PICC P&C a 'better than market' rating and predicting the company's net income attributable to parent from 2024 to 2026 to be 28.418/31.982/34.243 billion yuan, and earnings per share to be 1.28/1.44/1.54 yuan/share. The company's business model has the 'dual-wheel drive' advantage of asset and liability end, and with the current ongoing recovery of production and life and the rise of electric vehicles and other opportunities, the reasonable target price is expected to be 11.45-12.1 Hong Kong dollars. Guosen's main point of view is as follows: PICC P&C is the property insurance of China.
Guosen Securities: Maintains a "better than market" rating for Juzi Biotechnology, as its performance during the June 18th promotion continues to be impressive.
Guosen Securities released a research report, maintaining a "better than the market" rating for Juzi Bio (02367). Considering the outstanding performance of the 618 promotion and the continuous iteration of new products driving the company's annual performance growth, the net income attributable to the parent company for 2024-2026 was raised to RMB 1.837 billion, RMB 2.318 billion, and RMB 2.778 billion (original values were RMB 1.747 billion, RMB 2.245 billion, and RMB 2.69 billion), respectively. The report stated that relying on the rapid development of industrialization empowered by many years of accumulation in the collagen protein track in the early stage, the company has now established a deep brand awareness of recombined collagen protein. The continuous and outstanding performance of the two brands in the 618 promotion also confirms the company's
Private Companies Account for 50% of Guosen Securities Co., Ltd.'s (SZSE:002736) Ownership, While Institutions Account for 31%
Key Insights The considerable ownership by private companies in Guosen Securities indicates that they collectively have a greater say in management and business strategy 56% of the business is held
Guosen Securities: Maintains Chow Tai Fook's "Outperform" rating, with steady growth in performance recovery for the 2024 fiscal year.
Guosen Securities released a research report stating that it maintains a "better than the market" rating for Chow Tai Fook (01929). In the short term, high volatility in gold prices may suppress demand from end consumers, and the increase of low gross margin gold products may affect the overall gross margin. Therefore, the company's net income attributable to shareholders for the fiscal years 2025-2026 is lowered to HKD 7.249/8.143 billion (previous value was HKD 8.761/9.785 billion), and the forecast for fiscal year 2027 is increased to HKD 8.976 billion. Looking ahead to the whole year, gold jewelry still has continuous growth momentum supported by the gold price and demand for value preservation. As a leader in the gold jewelry industry,
Guosen Securities: Maintains a rating of outperform on Tianli International Holdings with a target price of HKD 5.34-5.90.
Guosen Securities issued a research report on Tianli Int Hldg (01773), a leading private education group in the transformation pace. With outstanding teaching achievements and diversified academic planning services, the group's internal student numbers are steadily increasing. The growth potential of the high school and K12 associate businesses is certain and elastic, and the entrustment business is also expected to increase profitability. Guosen Securities maintains Tianli Int Hldg's rating above the market and has a target price of HKD 5.34-5.90. The private education group in the transformation pace. Since the establishment of its first school in 2002, the company has been committed to building and operating K12 schools and achieving...
No Data